Copyright
©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 109859
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109859
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.109859
Table 1 Grouping of experimental mice
| No. | Groups | Injections | Number of mice | |
| 1 | Subcutaneous injection | Control | Vehicle | 14 |
| 2 | Model | Vehicle | 14 | |
| 3 | Low | 5 × 104 ADSCs | 14 | |
| 4 | Medium | 5 × 105 ADSCs | 14 | |
| 5 | High | 1 × 106 ADSCs | 14 | |
| 6 | Intramuscular injection | Control | Vehicle | 7 |
| 7 | Model | Vehicle | 7 | |
| 8 | Medium | 5 × 105 ADSCs | 7 | |
| 9 | High | 1 × 106 ADSCs | 7 | |
Table 2 Grouping of experimental rats
| No. | Groups | Injections | Number of rats | |
| 1 | Subcutaneous injection | Control | Vehicle | 14 |
| 2 | Model | Vehicle | 14 | |
| 3 | Low | 2 × 105 ADSCs | 14 | |
| 4 | Medium | 5 × 105 ADSCs | 14 | |
- Citation: Cao J, Liu ZC, An WQ, Zhang S, Zhang X, Li LJ, Ji HL, Long X, Yang YM. Optimizing adipose-derived stem cell therapy for diabetic foot ulcers. World J Diabetes 2025; 16(11): 109859
- URL: https://www.wjgnet.com/1948-9358/full/v16/i11/109859.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i11.109859
